Changeflow GovPing Healthcare & Life Sciences FDA PRIA Reference SBA Size Standards Update
Routine Notice Amended Final

FDA PRIA Reference SBA Size Standards Update

Email

Summary

The FDA has posted an update regarding the Presolicitation Information and Analysis (PRIA) Reference, specifically concerning Small Business Administration (SBA) size standards. This notice updates the reference document used by the agency for certain regulatory processes.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA has updated its PRIA Reference document to reflect current Small Business Administration (SBA) size standards. This update is primarily informational, providing revised benchmarks for classifying businesses as small entities for the purposes of the PRIA process. The document is available for download from regulations.gov.

While this update does not introduce new compliance obligations, regulated entities, particularly drug and medical device manufacturers, should be aware of the revised size standards. These standards may affect how their business is classified for certain FDA regulatory submissions and processes. Compliance officers should ensure they are referencing the most current SBA size standards when interacting with the FDA's PRIA process.

What to do next

  1. Review updated PRIA Reference document for current SBA size standards
  2. Ensure internal classifications align with updated SBA size standards for relevant FDA processes

Archived snapshot

Mar 19, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

Download File

Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Geographic scope
National (US) National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Small Business Administration Regulatory Policy

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!